TN2010000266A1 - Oxazolidinones for the treatment and/or prophylaxis of heart failure - Google Patents
Oxazolidinones for the treatment and/or prophylaxis of heart failureInfo
- Publication number
- TN2010000266A1 TN2010000266A1 TN2010000266A TN2010000266A TN2010000266A1 TN 2010000266 A1 TN2010000266 A1 TN 2010000266A1 TN 2010000266 A TN2010000266 A TN 2010000266A TN 2010000266 A TN2010000266 A TN 2010000266A TN 2010000266 A1 TN2010000266 A1 TN 2010000266A1
- Authority
- TN
- Tunisia
- Prior art keywords
- heart failure
- prophylaxis
- treatment
- oxazolidinones
- disorders related
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 5
- 238000011321 prophylaxis Methods 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 3
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 2
- 208000019622 heart disease Diseases 0.000 abstract 2
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US740607P | 2007-12-11 | 2007-12-11 | |
| PCT/EP2008/010211 WO2009074249A1 (fr) | 2007-12-11 | 2008-12-03 | Oxazolidinones pour le traitement et/ou la prophylaxie de l'insuffisance cardiaque |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000266A1 true TN2010000266A1 (en) | 2011-11-11 |
Family
ID=40404481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TN2010000266A TN2010000266A1 (en) | 2007-12-11 | 2010-06-09 | Oxazolidinones for the treatment and/or prophylaxis of heart failure |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20110003804A1 (fr) |
| EP (1) | EP2229173A1 (fr) |
| JP (1) | JP2011506363A (fr) |
| KR (1) | KR20110010689A (fr) |
| CN (1) | CN101896185A (fr) |
| AU (1) | AU2008335922A1 (fr) |
| BR (1) | BRPI0820964A2 (fr) |
| CA (1) | CA2708418C (fr) |
| DO (1) | DOP2010000156A (fr) |
| IL (1) | IL205675A (fr) |
| MA (1) | MA31902B1 (fr) |
| MX (1) | MX2010005545A (fr) |
| NZ (1) | NZ586002A (fr) |
| RU (2) | RU2494740C2 (fr) |
| SV (1) | SV2010003578A (fr) |
| TN (1) | TN2010000266A1 (fr) |
| UA (1) | UA99638C2 (fr) |
| WO (1) | WO2009074249A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2459555B1 (fr) * | 2009-07-31 | 2021-11-03 | KRKA, D.D., Novo Mesto | Méthodes de cristallisation de rivaroxaban |
| CN103626749A (zh) * | 2012-08-21 | 2014-03-12 | 苏州泽璟生物制药有限公司 | 取代的噁唑烷酮化合物和包含该化合物的药物组合物及其用途 |
| US20200200774A1 (en) * | 2017-06-20 | 2020-06-25 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for identifying whether patients with acute decompensated heart failure (adhf) exhibit a hypercoagulable state |
| WO2019093502A1 (fr) * | 2017-11-09 | 2019-05-16 | 国立大学法人 東京医科歯科大学 | Inhibiteur de l'expression de facteurs favorisant le cancer, méthode de criblage pour principe actif de celui-ci, cassette d'expression utile dans ladite méthode, médicament de diagnostic et méthode de diagnostic |
| JP6574041B2 (ja) * | 2017-12-15 | 2019-09-11 | エルメッド株式会社 | リバーロキサバン含有医薬組成物 |
| EP4021507A1 (fr) * | 2019-08-30 | 2022-07-06 | AstraZeneca AB | Méthodes de traitement de l'insuffisance cardiaque à fraction d'éjection réduite avec la dapagliflozine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU667198B2 (en) * | 1991-11-01 | 1996-03-14 | Pharmacia & Upjohn Company | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| ES2134870T3 (es) * | 1993-05-01 | 1999-10-16 | Merck Patent Gmbh | Antagonistas del receptor de adhesion. |
| DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
| AR060354A1 (es) * | 2006-04-06 | 2008-06-11 | Schering Corp | Terapias de combinacion antagonistas receptor trombina (tra) |
-
2008
- 2008-12-03 BR BRPI0820964-2A patent/BRPI0820964A2/pt not_active IP Right Cessation
- 2008-12-03 UA UAA201008619A patent/UA99638C2/ru unknown
- 2008-12-03 CA CA2708418A patent/CA2708418C/fr not_active Expired - Fee Related
- 2008-12-03 MX MX2010005545A patent/MX2010005545A/es active IP Right Grant
- 2008-12-03 JP JP2010537292A patent/JP2011506363A/ja active Pending
- 2008-12-03 NZ NZ586002A patent/NZ586002A/en not_active IP Right Cessation
- 2008-12-03 KR KR1020107012797A patent/KR20110010689A/ko not_active Ceased
- 2008-12-03 AU AU2008335922A patent/AU2008335922A1/en not_active Abandoned
- 2008-12-03 EP EP08860784A patent/EP2229173A1/fr not_active Withdrawn
- 2008-12-03 RU RU2010128442/15A patent/RU2494740C2/ru not_active IP Right Cessation
- 2008-12-03 WO PCT/EP2008/010211 patent/WO2009074249A1/fr not_active Ceased
- 2008-12-03 CN CN2008801209375A patent/CN101896185A/zh active Pending
- 2008-12-03 US US12/746,661 patent/US20110003804A1/en not_active Abandoned
-
2010
- 2010-05-11 IL IL205675A patent/IL205675A/en unknown
- 2010-05-25 DO DO2010000156A patent/DOP2010000156A/es unknown
- 2010-05-26 SV SV2010003578A patent/SV2010003578A/es unknown
- 2010-06-08 MA MA32895A patent/MA31902B1/fr unknown
- 2010-06-09 TN TN2010000266A patent/TN2010000266A1/fr unknown
-
2013
- 2013-07-22 RU RU2013134140/15A patent/RU2013134140A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010005545A (es) | 2010-07-30 |
| US20110003804A1 (en) | 2011-01-06 |
| IL205675A (en) | 2013-10-31 |
| DOP2010000156A (es) | 2011-02-15 |
| NZ586002A (en) | 2012-06-29 |
| CA2708418A1 (fr) | 2009-06-18 |
| EP2229173A1 (fr) | 2010-09-22 |
| RU2010128442A (ru) | 2012-01-20 |
| WO2009074249A1 (fr) | 2009-06-18 |
| CA2708418C (fr) | 2013-11-12 |
| BRPI0820964A2 (pt) | 2015-07-14 |
| IL205675A0 (en) | 2010-11-30 |
| SV2010003578A (es) | 2011-02-21 |
| RU2013134140A (ru) | 2015-01-27 |
| JP2011506363A (ja) | 2011-03-03 |
| RU2494740C2 (ru) | 2013-10-10 |
| AU2008335922A1 (en) | 2009-06-18 |
| CN101896185A (zh) | 2010-11-24 |
| MA31902B1 (fr) | 2010-12-01 |
| UA99638C2 (ru) | 2012-09-10 |
| KR20110010689A (ko) | 2011-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN01233A (fr) | ||
| GB0625648D0 (en) | Compounds | |
| MY150285A (en) | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use | |
| MX2009014235A (es) | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. | |
| MY147994A (en) | Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors | |
| UA105036C2 (uk) | Амінотетралінові похідні, фармацевтична композиція, яка їх містить, і їх застосування в терапії | |
| MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
| WO2011044506A3 (fr) | Composés sulfonés et leurs procédés de fabrication et d'utilisation | |
| NO20082120L (no) | Behandling og forebyggelse av mikroangiopati | |
| NO20091655L (no) | Substituerte dihydropyrazoloner for behandling av kardiovaskulaere og hematologiske sykdommer | |
| MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
| MA32272B1 (fr) | Inhibiteurs de raf de pyrazole [3,4-b]pyridine | |
| TN2012000428A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
| PT2222669E (pt) | Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p) | |
| NO20084328L (no) | Nye forbindelser | |
| PH12013500007A1 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| JO2645B1 (en) | Vehicles | |
| UA102238C2 (en) | 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof | |
| TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
| MY150931A (en) | Substituted oxazolidinones and their use | |
| TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
| BRPI0911678B8 (pt) | maleato de orvepitant cristalino anidro, composição farmacêutica compreedendo o dito maleato e uso do mesmo para o tratamento ou profilaxia de doenças do sistema nervoso central | |
| ATE475651T1 (de) | Aryl-substituierte heterozyklen und ihre verwendung |